Article thumbnail

Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers

By Hiddo J L Heerspink, C David Sjöström, Silvio E Inzucchi, Melissa K Hallow, Valerie A Cain, Peter Rossing, Bergur V Stefansson and Peter Sartipy
Topics: /dk/atira/pure/researchoutput/pubmedpublicationtype/D016428, Journal Article
Publisher: 'Wiley'
Year: 2019
DOI identifier: 10.1111/dom.13579
OAI identifier:

Suggested articles

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.